INDUSTRY PARTICIPATION MANUAL

Industry Program Onboarding

Please liaise directly with your nominated speakers and chairs to confirm their availability and requirements.

All speakers and chairs must be registered to be able to attend and present at the session. You can use one of your sponsorship or KOL complimentary registrations to register your speaker for free or you can purchase additional registrations. 

If you are not sure what registration type is more suitable for your speakers, please contact us

Naz Barootian
Sponsorship Relations Manager
sponex@aplarcongress.com 

Onboarding Form

Please complete industry program onboarding form as required by the deadline indicated in the checklist and deadlines. Failure to do so may result in our inability to provide the appropriate service/s and may result in additional fees.

DEADLING: 5 May 2021

You will be required to provide:

  • Session title
  • Synopsis
  • Format of presentation e.g.
    • 10:20 – Introduction (5 mins)
    • 10:25 – Speaker 1 (15 mins)
    • 10:40 – Speaker 2 (15 mins)
    • 11:55 – Speaker 3 (15 mins)
    • 11:10 – Q&A (25 mins)
  • Location of presentation (live in Kyoto or virtually)
  • Chair name and contact details (including bio and photo)
  • Presenter name and contact details (including bio and photo)

 

You will be able to submit a partly completed form and log back in at a later stage to update or add more information.  Minimum requirement for 5 May 2021 includes: Session title, location of presentation, presenter and chair photo and bio. The rest of the information should be provided by 1 June 2021. 

 If you require any assistance with this, please contact us.

Naz Barootian
Sponsorship Relations Manager
sponex@aplarcongress.com

 

Signage placement guidance for industry program

You can bring free-stand banners for the duration of your session. Please advise if you are bringing any signage with you. Outside of room: two (2) hours prior to your session starting, you are permitted to place one (1) pull up banner (850 x 2010mm) directly outside of your session room. This must be removed 15 minutes prior to the end of your session.

Pull Up Banner Size: 850 x 2000mm

You can provide marketing materials to the Industry Symposium attendees for your session when they are entering the session. Any marketing materials not taken by the attendees must be cleared from the room by the Industry Partner before the close of the Industry Symposium. Seat drops are not available. Please note that no flyer distribution or solicitation of delegates may take place for your industry program symposia or workshops outside the confines of your exhibition booth.

AV Specifications

The following AV is included in the standard package:

  • One (1) room screen
  • Projector set at 16:9 ratio
  • Lectern and lectern microphone


Additional AV may be hired, please include your interest in specific requirements in your industry program portal.

Speaker Preparation

ALL presentations, regardless of virtual or in-person, need to be pre-recorded and submitted to the congress organisers by the specified date. If you have in-person presenters they can still present live however the pre-recorded content will be used as a back up for virtual attendees in the case of technical faults on the day of presentation.

In-person speakers

  • In-person speakers will submit their pre-recorded presentation by the due date listed on this document. This pre-recording will only be used if the facilities fail on the day and the virtual attendees cannot access the in-room stream link.
  • On the day of presentation, speakers will need to submit their presentation slides onsite to our speaker preparation room where you will be able to go through the slides and rehearse with your speakers.
  • Room setup (schematic by room)
  • All times listed include set-up, presentation and pack up time. Pre-presentation room access may be available for some timeslots and subject to agreement with the APLAR 2021 Secretariat.

Virtual speakers

  • Virtual speakers will submit their pre-recorded presentation by the due date listed in this document. This presentation will be played to the virtual attendees and the in-person attendees in Kyoto simultaneously. Virtual speakers will then join the zoom link for the live Q&A that will be streamed to the Kyoto convention centre and the virtual platform.
  • The zoom links will be sent to the virtual speakers 7 days prior to the congress commencement.

Green room/Zoom room

  • The green room (zoom link) is open just (approximately 10- minutes) prior to the session commencement. The speakers/moderators will have their audio and visual tested by the technician located on the zoom room. The technician will provide instruction to the speakers prior to going live to the Kyoto and virtual attendees.

Q&A

  • Questions will be submitted through the virtual platform by in-person delegates and virtual delegates. These will then be read out by the chairperson.

The industry program is now available via our website at: www.aplar2021.com/industry-program. Please note program times may be subject to change.

QR Code Scanning - In Person

All exhibitors and industry program sessions will receive an individual QR code to enable delegates to scan into your booth.

The QR code may be scanned with the delegate’s phone through the APLAR 2021 congress app. 

This QR code will be sent upon receipt of payment. We suggest you incorporate this into your booth design for maximum engagement.

The following information will be distributed.

  • Delegates will be scanned upon entry into the workshop/symposium room
  • Reports will be distributed in Excel format to partners by end of day
  • Exhibition booth scanning data will be distributed post congress
  • These reports will include name, organisation, email and country
Industry Program Promotion

All industry symposia are included in secretariat led promotion of the industry program, through a dedicated EDM.

Dedicated Industry Program Promotion - #1

Content: 3 months to Congress
Date: 25 May 2021

Dedicated Industry Program Promotion - #2

Content: 2 months to Congress
Date: 28 June 2021

Dedicated Industry Program Promotion - #3

Content: 1 month to Congress
Date: 27 July 2021

  • Full industry program published with times and dates and industry partner logos.
  • Symposium title included.
  • Links to APLAR 2021 Industry Program page on the website.


If we have not received the information noted above by the stated deadline, your items will not be included.

CSF blue logo transparent 300x300 (ACR+APLAR)

CSF

The Cytokine Signalling Forum (CSF) is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice. Visit our website at www.cytokinesignalling.com or follow us on social media at links below
Contact
Astellas logo

Sales Operation Area Management Support, Japan Commercial, Astellas Pharma Inc.

Janssen_300x300

Janssen, a division of Johnson & Johnson

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.

Janssen Asia Pacific is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Lilly logo

Eli Lilly Japan K.K.

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work.

Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Abbvie logo

AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Bristol Myers Squibb logo

Bristol Myers Squibb K.K.

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Gilead logo

Gilead Sciences K.K.

Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. Gilead’s Inflammation R&D team is focused on improving therapeutic options for the treatment of multiple inflammatory conditions through a comprehensive clinical trial program evaluating novel agents with the goal of advancing patient care.

Novartis logo

Novartis Pharma K.K.

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. We consistently rank among the world’s top companies investing in research and development.

Pfizer logo

Pfizer. Japan Inc

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Asahi Kasei Logo

Asahi Kasei Pharma Corporation

Asahi Kasei Pharma discovers, develops, manufactures, and delivers prescription drugs in the fields of orthopedics, circulatory, urology, the immune system, and the central nervous system.

Pharmaceuticals from Asahi Kasei Pharma include Teribone™ for osteoporosis and Elcitonin™ Injection 20S for osteoporosis pain, the Recomodulin™ anticoagulant, each of which has a competitive position in its respective market.

Kevzara® is a human monoclonal antibody that blocks the action of interleukin-6 (IL-6) by binding to IL-6 receptors, for the indication of rheumatoid arthritis in patients who have had an inadequate response to conventional treatments.

Kevzara® is a registered trademark of Sanofi Biotechnology.

The product information is intended for general information purposes. The names, descriptions, and labeling of approved products are of Japan origin.

Product availability, names, indications, and presentations may vary from country to country.

Boehringer Ingelheim logo

Boehringer Ingelheim

Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of

19 billion euros. Our significant investment of almost 3.5 billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.

We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.

More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.com or in our annual report: www.annualreport.boehringer-ingelheim.com.

Janssen logo

Janssen Pharmaceutical KK & Mitsubishi Tanabe Pharma Corporation

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.

Janssen Asia Pacific is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Chugai logo

Chugai Pharmaceutical Co., Ltd

Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs.

Daiichi-Sankyo logo

Daiichi Sankyo Co., Ltd.

GSK Logo

Glaxosmithkline

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

UCB logo

UCB Biopharma SRL

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines. Our ambition is to transform the lives of people living with severe diseases, with a focus in immunology and neurology.

CSF Logo

Cesas Medical

The Cytokine Signalling Forum (CSF) is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.

AWR logo

Association of Women in Rheumatology

AWIR is a global organization with more than 11,000 touchpoints and 8 global chapters/partners worldwide. AWIR’s mission is to promote the science and practice of Rheumatology, foster the advancement and education of women in Rheumatology, and advocate access to the highest quality health care, and the management of patients with Rheumatic diseases.

LG Chem logo

LG Chem

LG Chem, the leading chemical company, has strengthened market dominance starting from the Basic Materials & Chemicals business to Energy Solution, IT and Electronic Materials and Life Science area.

Life Sciences Company focuses at four major healthcare services including pharmaceutical, vaccine, medical device and biopharmaceutical.

Based on its own fundamental technology, LG Chem expanded its pipeline to include biosimilars in order to improve patient access to highly effective biological products.

LG Chem will continue to improve the quality of life by providing innovative portfolio of medicines across the world.

Contact
APLAR21-Placeholder (300x300)

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Contact